ANTI-INHIBITOR COAGULANT COMPLEX for Haemophilia a with anti factor viii: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 44 adverse event reports in the FDA FAERS database where ANTI-INHIBITOR COAGULANT COMPLEX was used for Haemophilia a with anti factor viii.
Most Reported Side Effects for ANTI-INHIBITOR COAGULANT COMPLEX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemorrhage | 380 | 26.4% | 19 | 55 |
| Treatment failure | 135 | 9.4% | 0 | 1 |
| Drug ineffective | 129 | 9.0% | 14 | 26 |
| Therapy partial responder | 104 | 7.2% | 72 | 21 |
| Haemarthrosis | 92 | 6.4% | 3 | 31 |
| Acquired haemophilia | 77 | 5.4% | 75 | 24 |
| Pre-existing disease | 74 | 5.2% | 74 | 22 |
| Death | 59 | 4.1% | 59 | 4 |
| Factor viii inhibition | 56 | 3.9% | 3 | 21 |
| Anti factor viii antibody positive | 49 | 3.4% | 2 | 6 |
| Joint swelling | 45 | 3.1% | 0 | 21 |
| Arthralgia | 44 | 3.1% | 0 | 15 |
| Haematoma | 40 | 2.8% | 2 | 18 |
| Fall | 38 | 2.6% | 3 | 20 |
| Muscle haemorrhage | 36 | 2.5% | 2 | 17 |
Other Indications for ANTI-INHIBITOR COAGULANT COMPLEX
Haemophilia (335)
Factor viii deficiency (317)
Acquired haemophilia (215)
Product used for unknown indication (213)
Prophylaxis (122)
Haemorrhage (116)
Haemorrhage prophylaxis (56)
Post procedural haemorrhage (48)
Haemostasis (32)
Factor viii inhibition (27)
Other Drugs Used for Haemophilia a with anti factor viii
EMICIZUMAB-KXWH (128)
EMICIZUMAB (70)
COAGULATION FACTOR VIIA RECOMBINANT HUMAN (43)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (9)
RITUXIMAB (6)
ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT (5)